Chemical Screening Identifies Enhancers of Mutant Oligodendrocyte Survival and Unmasks a Distinct Pathological Phase in Pelizaeus-Merzbacher Disease.

Elitt MS, Shick HE, Madhavan M, Allan KC, Clayton BLL, Weng C, Miller TE, Factor DC, Barbar L, Nawash BS, Nevin ZS, Lager AM, Li Y, Jin F, Adams DJ, Tesar PJ.

Stem Cell Reports. 2018 Aug 23. pii: S2213-6711(18)30320-5. doi: 10.1016/j.stemcr.2018.07.015. [Epub ahead of print] PubMed PMID: 30146490.